VYNE Therapeutics (VYNE) Short Interest Ratio & Short Volume → Banking Apocalypse Ahead: Secure Your Savings Today! (From Weiss Ratings) (Ad) Free VYNE Stock Alerts $2.59 +0.01 (+0.39%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends VYNE Therapeutics Short Interest DataCurrent Short Interest57,400 sharesPrevious Short Interest82,000 sharesChange Vs. Previous Month-30.00%Dollar Volume Sold Short$160,720.00Short Interest Ratio0.6 Days to CoverLast Record DateMay 15, 2024Outstanding Shares14,530,000 sharesFloat Size12,390,000 sharesShort Percent of Float0.46%Today's Trading Volume17,088 sharesAverage Trading Volume103,151 sharesToday's Volume Vs. Average17% Short Selling VYNE Therapeutics ? Sign up to receive the latest short interest report for VYNE Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVYNE Short Interest Over TimeVYNE Days to Cover Over TimeVYNE Percentage of Float Shorted Over Time Ad Colonial MetalsWARNING about the death of the U.S. dollar…Where do you turn during times of economic uncertainty? Many elites trust storing their wealth in gold (which has historically boomed when the dollar’s value has plummeted!)Get Colonial Metals' new Precious Metals Investment Guide. VYNE Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202457,400 shares $160,720.00 -30.0%0.5%0.6 $2.80 4/30/202482,000 shares $206,640.00 -15.3%0.7%0.8 $2.52 4/15/202496,800 shares $248,776.00 +13.1%0.8%0.9 $2.57 3/31/202485,600 shares $262,792.00 +590.3%0.7%0.7 $3.07 3/15/202412,400 shares $24,924.00 -63.4%0.1%0.1 $2.01 2/29/202433,900 shares $75,597.00 -5.3%0.3%0.3 $2.23 Get the Latest News and Ratings for VYNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VYNE Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202435,800 shares $77,328.00 -31.8%0.3%0.4 $2.16 1/31/202452,500 shares $89,775.00 -40.3%0.4%0.5 $1.71 1/15/202488,000 shares $181,280.00 No Change0.7%0.2 $2.06 12/31/202388,000 shares $205,040.00 +1,157.1%N/A0.2 $2.33 12/15/20237,000 shares $19,180.00 -94.4%0.1%0 $2.74 11/30/2023124,800 shares $413,088.00 -15.0%1.0%0.4 $3.31 11/15/2023146,800 shares $604,816.00 +150.9%1.2%0.4 $4.12 10/31/202358,500 shares $178,425.00 +11.6%1.9%0.2 $3.05 10/15/202352,400 shares $144,100.00 -7.6%1.7%3.3 $2.75 9/30/202356,700 shares $229,068.00 -8.1%1.8%3.5 $4.04 9/15/202361,700 shares $237,545.00 -0.2%2.0%4.1 $3.85 8/31/202361,800 shares $268,830.00 -19.7%2.0%3.7 $4.35 8/15/202377,000 shares $373,450.00 +13.1%2.4%3.7 $4.85 7/31/202368,100 shares $316,665.00 +3.8%2.2%2 $4.65 7/15/202365,600 shares $276,832.00 -6.0%2.1%0.7 $4.22 6/30/202369,800 shares $286,180.00 -5.6%2.2%0.1 $4.10 6/15/202373,900 shares $352,281.30 +13.7%2.4%0.1 $4.77 5/31/202365,000 shares $408,850.00 -29.3%2.1%0.1 $6.29 5/15/202391,900 shares $705,792.00 -55.6%2.9%0.1 $7.68 4/30/2023206,800 shares $1.09 million +119.1%6.6%0.3 $5.26 4/15/202394,400 shares $256,768.00 -3.9%3.0%0.1 $2.72 3/31/202398,200 shares $302,456.00 +30.2%3.1%1.7 $3.08 3/15/202375,400 shares $192,270.00 +38.1%2.3%1 $2.55 2/28/202354,600 shares $182,091.00 -2.5%1.7%0.8 $3.34 2/15/202356,000 shares $196,560.00 -94.6%1.8%0.8 $3.51 1/31/20231,030,000 shares $267,800.00 -29.0%N/A0.8 $0.26 1/15/20231,450,000 shares $388,311.45 +105.2%N/A1.2 $0.27 12/30/2022706,800 shares $106,020.00 -7.4%N/A0.6 $0.15 12/15/2022763,400 shares $129,472.64 -4.3%N/A3.5 $0.17 11/30/2022797,700 shares $185,545.02 +3.5%N/A4.3 $0.23 11/15/2022770,600 shares $189,297.89 -3.6%N/A4.3 $0.25 10/31/2022799,300 shares $204,301.08 +3.2%N/A2.7 $0.26 10/15/2022774,400 shares $187,792.00 +0.0%N/A2.6 $0.24 9/30/2022774,200 shares $172,724.02 -22.4%N/A2.6 $0.22Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. 9/15/2022997,900 shares $282,405.70 +48.9%N/A3.1 $0.28 8/31/2022670,200 shares $209,973.66 -6.0%N/A1.9 $0.31 8/15/2022713,200 shares $228,224.00 -4.9%N/A1.9 $0.32 7/31/2022750,300 shares $324,204.63 -15.5%N/A2.5 $0.43 7/15/2022887,400 shares $399,330.00 -22.8%N/A2.6 $0.45 6/30/20221,150,000 shares $447,350.00 -9.5%N/A2 $0.39 6/15/20221,270,000 shares $660,400.00 +5.0%N/A2 $0.52 5/31/20221,210,000 shares $492,954.00 -11.7%N/A1.8 $0.41 5/15/20221,370,000 shares $545,260.00 -12.7%N/A2 $0.40 4/30/20221,570,000 shares $659,400.00 +8.3%N/A2.1 $0.42 4/15/20221,450,000 shares $767,050.00 +57.0%N/A1.7 $0.53 3/31/2022923,800 shares $600,562.38 -19.0%N/A0.8 $0.65 3/15/20221,140,000 shares $638,400.00 -22.5%N/A1 $0.56 2/28/20221,470,000 shares $796,740.00 -6.4%N/A0.5 $0.54 2/15/20221,570,000 shares $893,487.00 -23.4%N/A0.6 $0.57 1/31/20222,050,000 shares $1.27 million +12.6%N/A0.7 $0.62 1/15/20221,820,000 shares $1.25 million -12.5%N/A0.7 $0.69 12/31/20212,080,000 shares $2.12 million -34.0%N/A0.9 $1.02 12/15/20213,150,000 shares $3.59 million +283.4%N/A1.3 $1.14 11/30/2021821,600 shares $846,248.00 -11.7%N/A0.6 $1.03 11/15/2021930,900 shares $1.19 million +5.5%N/A1.3 $1.28 10/29/2021882,000 shares $1.18 million +1.5%1.7%1 $1.34 10/15/2021869,400 shares $1.06 million -9.6%1.7%1 $1.22 9/30/2021962,100 shares $1.34 million -23.0%1.9%1.3 $1.39 9/15/20211,250,000 shares $1.85 million -11.4%2.5%1.5 $1.48 8/31/20211,410,000 shares $2.40 million -50.4%2.8%1.6 $1.70 8/13/20212,840,000 shares $5.06 million -6.6%5.6%3.2 $1.78 7/30/20213,040,000 shares $8.21 million +7.8%6.0%4.1 $2.70 7/15/20212,820,000 shares $7.76 million +9.7%5.6%3.2 $2.75 6/30/20212,570,000 shares $9.02 million -35.6%5.1%2.8 $3.51 6/15/20213,990,000 shares $14.52 million -1.2%7.9%4.6 $3.64 5/28/20214,040,000 shares $15.96 million -7.3%8.0%4.6 $3.95 5/14/20214,360,000 shares $14.13 million +15.7%8.6%4.4 $3.24 4/30/20213,770,000 shares $19.34 million +13.2%7.5%2.5 $5.13 4/15/20213,330,000 shares $18.78 million -0.9%6.6%1.4 $5.64 3/31/20213,360,000 shares $22.14 million +14.7%6.7%1.4 $6.59 3/15/20212,930,000 shares $21.65 million +7.7%5.8%1.3 $7.39 2/26/20212,720,000 shares $21.46 million -71.8%5.4%1.2 $7.89 2/12/20219,660,000 shares $102.78 million -7.9%19.7%4.8 $10.64 1/29/202110,490,000 shares $93.57 million +15.2%5.8%1.6 $8.92 1/15/20219,110,000 shares $60.13 million No Change5.7%2.4 $6.60 8/14/20209,960,000 shares $64.14 million -3.7%N/A2.2 $6.44 7/31/202010,340,000 shares $66.59 million +19.0%N/A2.1 $6.44 7/15/20208,690,000 shares $56.31 million -22.7%N/A1.7 $6.48 6/30/202011,240,000 shares $81.38 million +62.0%N/A2.1 $7.24 6/15/20206,940,000 shares $61.07 million +44.9%N/A1.4 $8.80 5/29/20204,790,000 shares $45.79 million +20.1%N/A1.2 $9.56 5/15/20203,990,000 shares $26.97 million -29.6%N/A1.4 $6.76 4/30/20205,670,000 shares $41.28 million +9.7%N/A2.8 $7.28 4/15/20205,170,000 shares $28.75 million +106.0%N/A3.7 $5.56Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. 3/31/20202,510,000 shares $26.91 million -5.0%N/A2.7 $10.72 3/13/20202,643,000 shares $31.93 million +389.2%18.5%2.6 $12.08 2/28/2020540,300 shares $6.38 million +4.8%3.8%1.5 $11.80 2/14/2020515,500 shares $10.45 million +3.3%3.6%2.6 $20.28 1/31/2020499,200 shares $9.19 million -11.6%4.3%3.1 $18.40 1/15/2020564,800 shares $15.66 million +81.1%4.8%3.9 $27.72 12/31/2019311,900 shares $5.79 million +112.6%2.7%2.5 $18.56 8/15/2019105,200 shares $1.33 million -33.1%0.8%2.1 $12.62 VYNE Short Interest - Frequently Asked Questions What is VYNE Therapeutics' current short interest? Short interest is the volume of VYNE Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 57,400 shares of VYNE short. 0.46% of VYNE Therapeutics' shares are currently sold short. Learn More on VYNE Therapeutics' current short interest. What is a good short interest ratio for VYNE Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VYNE shares currently have a short interest ratio of 1.0. Learn More on VYNE Therapeutics's short interest ratio. What is a good short interest percentage for VYNE Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.46% of VYNE Therapeutics' floating shares are currently sold short. Is VYNE Therapeutics' short interest increasing or decreasing? VYNE Therapeutics saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 57,400 shares, a decline of 30.0% from the previous total of 82,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is VYNE Therapeutics' float size? VYNE Therapeutics currently has issued a total of 14,530,000 shares. Some of VYNE Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. VYNE Therapeutics currently has a public float of 12,390,000 shares. How does VYNE Therapeutics' short interest compare to its competitors? 0.46% of VYNE Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to VYNE Therapeutics: Jaguar Health, Inc. (4.32%), Fortress Biotech, Inc. (11.49%), Eyenovia, Inc. (10.27%), Unicycive Therapeutics, Inc. (3.17%), Lexaria Bioscience Corp. (1.40%), DURECT Co. (3.13%), Cara Therapeutics, Inc. (5.23%), NRx Pharmaceuticals, Inc. (7.00%), CASI Pharmaceuticals, Inc. (0.83%), HCW Biologics Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short VYNE Therapeutics stock? Short selling VYNE is an investing strategy that aims to generate trading profit from VYNE Therapeutics as its price is falling. VYNE shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against VYNE Therapeutics? A short squeeze for VYNE Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VYNE, which in turn drives the price of the stock up even further. How often is VYNE Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VYNE, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Jaguar Health Short Interest Data Fortress Biotech Short Interest Data Eyenovia Short Interest Data Unicycive Therapeutics Short Interest Data Lexaria Bioscience Short Interest Data DURECT Short Interest Data Cara Therapeutics Short Interest Data NRx Pharmaceuticals Short Interest Data CASI Pharmaceuticals Short Interest Data HCW Biologics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VYNE) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersRevealed: The Unknown Biotech Powering AI in HealthcareBehind the MarketsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VYNE Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.